MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
MMSC is an actively managed ETF that utilizes a multi-manager approach to provide exposure to small-cap US growth stocks.
US
EQUITY
Active
MANAGEMENT STYLE
$ 53.0 M
ASSETS UNDER MGMT
95 bp
EXPENSES
Fund Basics
| Inception date | Oct 13, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| XOMETRY, INC. CLASS A | 1.4 % |
| NLIGHT, INC. | 1.4 % |
| TRAVERE THERAPEUTICS, INC. | 1.3 % |
| US DOLLAR | 1.3 % |
| GUARDANT HEALTH, INC. | 1.3 % |
| CRINETICS PHARMACEUTICALS INC | 1.3 % |
| TWIST BIOSCIENCE CORP. | 1.2 % |
| FIRSTCASH, INC. | 1.2 % |
| SPYRE THERAPEUTICS INC | 1.1 % |
| JFROG LTD. | 1.1 % |
Constituent Breakdown
| Number of holdings | 210 |
| Herfindahl-Hirschman Index | 62 |
| Wgt avg mkt cap (mns) | $7,866 |
| Large cap (>$10bn) | 24.4% |
| Mid cap ($2-10bn) | 62.2% |
| Small cap (<$2bn) | 9.0% |
| Developed mkts. | 96.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 90.2 % |
 |
ISRAEL | 1.3 % |
 |
HONG KONG | 1.1 % |
 |
IRELAND | 0.9 % |
 |
CANADA | 0.9 % |
 |
BRITAIN | 0.6 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 13.9% | 29.7% | 17.4% | 17.9% | -- | -- | -- | 6.1% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | 0.0% |
| Total Returns | 13.9% | 29.7% | 17.4% | 17.9% | -- | -- | -- | 6.1% | Ann. Volatility | 25.6% | 24.2% | 25.2% | 23.0% | -- | -- | -- | 24.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.54 | 68% |
| MSCI EAFE | 1.09 | 50% |
| MSCI Emg Mkts | 0.74 | 56% |
Liquidity Measures
| Avg. volume (000) | 4 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.43% |
Technical Indicators
| 30d moving avg. (EMA) | $27.90 |
| Relative strength (RSI) | 48 |
| MACD/Signal | -0.29/-0.16 |
| Bollinger Bands (Upper/Lower) | $29.24/$26.78 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MMSC |
Expenses vs. MMSC |
ALTAR Score™ vs. MMSC |
|---|---|---|---|---|
| VBK | Vanguard Small-Cap Growth ETF | 22.8% | -88 bp | +1.9% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 22.7% | -89 bp | +3.2% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 22.6% | -25 bp | +2.9% |
| IWO | iShares Russell 2000 Growth ETF | 20.7% | -71 bp | +1.2% |
| PSC | Principal U.S. Small-Cap ETF | 18.3% | -57 bp | +4.5% |
| STXK | Strive Small-Cap ETF | 17.7% | -77 bp | +5.3% |
| VTWG | Vanguard Russell 2000 Growth ETF | 17.5% | -85 bp | +1.3% |
| FESM | Fidelity Enhanced Small Cap ETF | 17.2% | -67 bp | +2.8% |
| DBSC | Deepwater Beachfront Small Cap ETF | 17.1% | -10 bp | +2.3% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 17.0% | -24 bp | +0.4% |
Risk and Returns: MMSC vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/9/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
0.1%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. MMSC's ALTAR Score™ is approximately -2.6 standard
deviations above the category average. This places MMSC in the 1st percentile
among funds in the category.
Sell-Side Consensus
$29.58
PRICE TARGET
+3.2%
UPSIDE